Cargando…
Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial
BACKGROUND: Pruritus in patients undergoing hemodialysis is a highly prevalent complication that affects quality of life. Several medications are currently used for the treatment of uremic pruritus, but these are not satisfactory. PG102P, which is prepared from Actinidia arguta, has an immune-modula...
Autores principales: | Kim, Yong Chul, Park, Jae Yoon, Oh, Sohee, Cho, Jang-Hee, Chang, Jae Hyun, Choi, Dae Eun, Park, Jung Tak, Lee, Jung Pyo, Kim, Sejoong, Kim, Dong Ki, Ryu, Dong-Ryeol, Lim, Chun Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883697/ https://www.ncbi.nlm.nih.gov/pubmed/31779697 http://dx.doi.org/10.1186/s13063-019-3753-1 |
Ejemplares similares
-
VolumE maNagement Under body composition monitoring in critically ill patientS on CRRT: study protocol for a randomized controlled trial (VENUS trial)
por: Oh, Hyung Jung, et al.
Publicado: (2018) -
The Incidence of Pruritus and Biochemical Marker Associated with Pruritus in Hemodialysis Patients
por: Noh, Soo Hyeon, et al.
Publicado: (2018) -
Robustification of RosettaAntibody and Rosetta SnugDock
por: Jeliazkov, Jeliazko R., et al.
Publicado: (2021) -
Evaluating a shared decision-making intervention regarding dialysis modality: development and validation of self-assessment items for patients with chronic kidney disease
por: Kim, Soojin, et al.
Publicado: (2022) -
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2020)